secwatch.observer — SEC 8-K summary
======================================

Issuer:     Compass Therapeutics, Inc. (CMPX)
CIK:        0001738021
Form:       8-K
Filed at:   2021-12-21T23:59:59+00:00
Accession:  0000950170-21-005307
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Julie Sunderland resigns from Compass Therapeutics Board
-----------------------------------------------------------------

- Julie Sunderland notified the Board of her resignation effective December 31, 2021.
- Resignation from the Board and all committees; not due to any disagreement with the company.
- She was an early venture investor and is departing for other professional endeavors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1738021/000095017021005307/0000950170-21-005307-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1738021/000095017021005307/cmpx-20211220.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-005307

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer